metformin alleviates lipopolysaccharide-induced acute lung injury through suppressing toll-like receptor 4 signaling

Authors

haleh vaez department of pharmacology, faculty of pharmacy, tabriz university of medical sciences, tabriz, iran and student research committee, tabriz university of medical sciences, tabriz, iran

moslem najafi department of pharmacology, faculty of pharmacy, tabriz university of medical sciences, tabriz, iran

negisa seyed toutounchi student research committee, tabriz university of medical sciences, tabriz, iran

jaleh barar research center for pharmaceutical nanotechnology, tabriz university of medical sciences, tabriz, iran

abstract

signaling amp-activated protein kinase (ampk), an energy sensing enzyme, has been implicated in controlling inflammation. in this study we investigated whether activation of ampk by metformin could protect the lung from lipopolysaccharide (lps)-induced acute injury by inhibitingng tlr4 pathway. male wistar rats were randomly divided into 3 groups (n=6): control group received normal saline (0.5 ml), lps group received lps (0.5 mg/kg), and metformin-treated group received lps and metformin (100 mg/kg). nine hours later nuclear factor-κb (nf-κb), phosphorylated, and non-phosphorylated ampk using western blot, and the rate of tlr4 mrna expression using real-time pcr were assessed in the lung tissue. to evaluate neutrophil infiltration, the myeloperoxidase (mpo) activity was measured. the severity of the lung damage was assessed by histological examinations. it was found that the ratio of p-ampkα to ampkα was significantly upregulated by 22% ( p <0.05) in the lungs obtained from the metformin group. in lps-treated rats, we observed a high expression of tlr4 in the tissue along with increased levels of myd88, nf-κb, and tnfα. metformin considerably reduced all these parameters. histological examinations revealed that metformin remarkably attenuated congestion and inflammatory cellular infiltration into the alveolar walls and also decreased mpo activity by 37% ( p <0.05). we conclude that metformin could protect the lung tissue against lps-evoked tlr4 activation and the protective effect can be related to the activation of ampk.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Metformin Alleviates Lipopolysaccharide-induced Acute Lung Injury through Suppressing Toll-like Receptor 4 Signaling.

Signaling AMP-activated protein kinase (AMPK), an energy sensing enzyme, has been implicated in controlling inflammation. In this study we investigated whether activation of AMPK by metformin could protect the lung from lipopolysaccharide (LPS)-induced acute injury by inhibitingng TLR4 pathway. Male Wistar rats were randomly divided into 3 groups (n=6): control group received normal saline (0.5...

full text

Toll-like receptor 4 monoclonal antibody attenuates lipopolysaccharide-induced acute lung injury in mice

Toll-like receptor 4 (TLR4) has an important role in the recognition of lipopolysaccharide (LPS) and in the activation of the inflammatory cascade. In the present study, the effect of TLR4 monoclonal antibody (mAb) on LPS-induced acute lung injury (ALI) was investigated in mice. A total of 45 male BALB/c mice were randomly divided into three groups, namely, the control (group C), sepsis (group ...

full text

Inhibiting toll-like receptor 4 signaling ameliorates pulmonary fibrosis during acute lung injury induced by lipopolysaccharide: an experimental study

BACKGROUND Toll-like receptor 4 (TLR4) is essential in lipopolysaccharide (LPS)-induced fibroblast activation and collagen secretion in vitro. However, its effects on the process of lung fibroblast activation and fibrosis initiation during LPS induced acute lung injury (ALI) remain unknown. The goal of the present study was to determine the effect of inhibiting TLR4 on LPS-induced ALI and fibro...

full text

Sevoflurane Inhibits Nuclear Factor-κB Activation in Lipopolysaccharide-Induced Acute Inflammatory Lung Injury via Toll-Like Receptor 4 Signaling

BACKGROUND Infection is a common cause of acute lung injury (ALI). This study was aimed to explore whether Toll-like receptors 4 (TLR4) of airway smooth muscle cells (ASMCs) play a role in lipopolysaccharide (LPS)-induced airway hyperresponsiveness and potential mechanisms. METHODS In vivo: A sensitizing dose of LPS (50 µg) was administered i.p. to female mice before anesthesia with either 3%...

full text

toll-like receptor 4 in ventilator-induced lung injuries

toll like receptors (tlrs) recognize pathogens and generate an immediate defense response by inducing the production of pro-inflammatory cytokines, which rapidly destroy or limit the pathogens. in their bridging role, tlr downstream signals link innate and adaptive immunity, particularly by mediating dc maturation and activation of pathogen specific t lymphocytes. these pathways lead to the act...

full text

Down-regulation of toll-like receptor 4 alleviates intestinal ischemia reperfusion injury and acute lung injury in mice

Intestinal ischemia reperfusion (IR) injury is a critical problem, which can cause intestinal injury locally and acute lung injury (ALI) distally by inflammatory responses and oxidative stress. Toll-like receptor 4 (TLR4) is involved in innate immune and inflammatory responses. This study was to determine whether TLR4 mutant can attenuate intestinal and lung injuries after intestinal IR. Wild t...

full text

My Resources

Save resource for easier access later


Journal title:
iranian journal of allergy, asthma and immunology

جلد ۱۵، شماره ۶، صفحات ۴۹۸-۵۰۷

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023